Riskpilot← Back to searchSign inGet full accessDERMCONSULT AS
ASActiveOrg 983542638Forhåpningen 3, 9011 TromsøMedical specialists activities · NACE 8622Est. 20010 employees
Revenue 2020
NOK 124K
-58% vs 2019
EBITDA margin
-50.6%
-160% vs 2019
Equity ratio
39.1%
Financial strength
Net profit 2020
NOK -48K
-166% vs 2019
| Revenue | NOK 124K | -58% |
| EBITDA | NOK -63K | -160% |
| Net profit | NOK -48K | -166% |
| Total assets | NOK 161K | -80% |
| Equity | NOK 63K | -44% |
| Employees | 0 | — |
Legal name
DERMCONSULT AS
Org number
983542638
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
19. juli 2001
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Markedsføre og tilby medisinske tjenester og det som står i forbindelse med dette. Eie og forvalte fast eiendom, samt det som naturlig står i forbindelse med dette. Selskapet kan delta i andre selskaper med beslektet virksomhet.
Address
Forhåpningen 3, 9011 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 1 001 | 439 | 436 | 298 | 124 |
| Staff expenses | −9 | −11 | −11 | −1 | −1 |
| EBITDA | 633 | 163 | 173 | 104 | −63 |
| Depreciation & amort. | −49 | −26 | −25 | −8 | −0 |
| EBIT | 584 | 137 | 148 | 96 | −63 |
| Net financials | 57 | 114 | 132 | −1 | 0 |
| Profit before tax | 641 | 251 | 280 | 95 | −62 |
| Tax | 147 | 49 | 56 | 21 | −14 |
| Net profit | 494 | 202 | 224 | 74 | −48 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 9 257 | 8 572 | 801 | 788 | 161 |
| Equity | 3 012 | 3 213 | 437 | 111 | 63 |
| Long-term debt | 5 634 | 4 953 | 190 | 92 | 18 |
| Short-term debt | 612 | 405 | 174 | 585 | 80 |
| Total debt | 6 245 | 5 359 | 364 | 677 | 98 |
EBITDA margin
-50.6%
This company
15.8%
Market median
-420% vs market
20162020
Equity ratio
39.1%
This company
38.2%
Market median
+2% vs market
20162020
Return on equity
-77.1%
This company
18.4%
Market median
-519% vs market
20162020
Net profit margin
-39.2%
This company
8.1%
Market median
-584% vs market
20162020
Asset turnover
0.77×
This company
1.12×
Market median
-31% vs market
20162020
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
20162020
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2015 | |
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DERMCONSULT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Solveig Alfreda Thora Falk | Board of Directors | 0 companies |
| Edvard Sigurd Falk | Chairman | 0 companies |